Australia may soon have the dangerous RU 486 abortion drug available nationwide after having it only in a very limited supply for the last few years. That’s despite the fact that the abortion drug has killed dozens of women and injured thousands more.
The Australian newspaper Australian Doctor indicates an application to make the abortion drug widely available has been submitted to the Therapeutic Goods Administration (TGA), the Australian equivalent of the FDA in the United States, by an unnamed company. The company has been working closely with abortion practitioner Caroline de Costa, who was the first to bring the abortion drug to the island nation.
De Costa told The Australian “she understood a firm was making an application to the TGA to market the drug” but she would not name the company “saying it was ‘very anxious not to have any publicity’ in the belief a controversy might ruin its chances of securing approval.”
Figures the FDA released in April in the United States show at least 14 women have died from using the abortion drug in the United States, dozens have died worldwide, and more than 2,200 have been injured by the mifepristone abortion drug in the U.S. alone.
News that the abortion drug could become ubiquitous across Australia follows on the heels of a May study involving women who used the abortion drug and participated in a clinical trial about its aftereffects. The Australian study found a high percentage of women using the dangerous RU 486 abortion drug required hospitalization — undermining the argument that the mifepristone pill is safe for women.
Doctors in the Australian state of South Australia conducted the study and published their results in the medical journal Australian Family Physician. Drs. Ea Mulligan and Hayley Messenger reviewed most of the 9,000 drug-based abortions done in the state in 2009 and 2010. They found 3.3 percent of women using the abortion drug in the first trimester were forced to seek medical treatment at a hospital afterwards because of complications or emergency problems.
The number jumped to 5.7 percent of women who used the abortion drug early in pregnancy when most abortion businesses dispense it to women. That is much higher than the 2.2 percent of women who have surgical abortions who are forced to seek hospital treatment because of complications and injuries sustained from it.
Of the women the doctors studied, two of the larger group of women getting surgical abortions suffered severe hemorrhage involving the loss of more than a liter of blood but four of the smaller group of women using the abortion drug had that happen. The incidence of complications and medical problems is likely higher than the results show because the study only captured care provided in public hospitals and not complications treated by general practitioners.
Margaret Tighe, of Right to Life Australia, told the Weekend Australian newspaper, “We always said that taking RU 486 would have a very deleterious effect on women’s health … taking a pill seems very easy, but what we are seeing here is there can be quite a lot of complications.”
Cherish Life Queensland president Teresa Martin agreed and said the study “blows out of the water” arguments abortion advocates have used to claim the abortion drug is safe for women.
Chris Gacek of the Family Research Council, in the United States, also responded to the study.
“For many years, FRC and the American Association of Pro Life Obstetricians and Gynecologists (AAPLOG) have been making the point that chemically-induced abortions are more dangerous than surgical abortions,” he said.
The study found 3.3% of the women who used RU-486 in the first trimester of pregnancy reported to an emergency room compared with 2.2% who used a surgical method and •5.7% of the women who used RU-486 had to be re-admitted to hospitals compared with 0.4% of surgical abortion patients. That is 1 in 18 patients.
The study also found that late-term abortions pose particular problems for women, with fully one-third of women who have them experiencing complications or medical problems. It also found, related to second-trimester abortions, 4% of the second trimester RU-486 abortions had “significant hemorrhage;” one of the two patients in this category required a transfusion.
The study came because the Therapeutic Goods Administration says 11,173 prescriptions for the abortion drug have been issued and South Australia has the most number of women who have destroyed unborn children using it. Australia has about 100,000 abortions — whether surgical or drug-induced — done annually.
See the results of the study at https://www.frcblog.com/wp-content/uploads/2011/05/Australian-AERs_RU486_201105mulligan.pdf